Yuichiro Ohe - National Cancer Center, Japan

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 781 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Non-reversed Great Saphenous Vein Grafts for Vascular Reconstruction after Resection of Lower-limb Sarcoma

Masaki Arikawa,Satoshi Akazawa,Daisuke Kageyama,Akira Kawai,Yuichiro Ohe,Masanobu Sakisaka,Shimpei Miyamoto

JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2024): 65-70

引用0浏览0WOS引用

Response to Dabrafenib Plus Trametinib on a Rare BRAF Mutation (V600_W604 Deletion-Insertion R) in an Advanced Non-Small Cell Lung Cancer Patient

Akiko Tamura,Ryoko Inaba Higashiyama,Tatsuya Yoshida, Yaya Satozono,Yuichiro Ohe

Thoracic cancerno. 18 (2024): 1454-1456

引用0浏览0WOS引用

Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together with Nivolumab Plus Ipilimumab: A Case Report

Yoshimasa Shiraishi,Takaaki Tokito,Ryo Toyozawa,Chiaki Inagaki,Hiroshi Nokihara,Yosuke Kawashima,Yuichiro Ohe,Isamu Okamoto

JOURNAL OF THORACIC ONCOLOGYno. 2 (2024): 337-343

引用0浏览0WOS引用

EGFR-Mutated Lung Adenocarcinoma with Li-Fraumeni Syndrome: The Imperative for Germline Testing in Patients with a Family History, A Case Report

Hiroyuki Fujii,Yusuke Okuma,Yuki Shinno,Tatsuya Yoshida,Yasushi Goto,Hidehito Horinouchi,Noboru Yamamoto,Yuichiro Ohe

JTO Clinical and Research Reportspp.100691, (2024)

引用0浏览0引用

[History of the Japanese Society of Medical Oncology]

Chikashi Ishioka,Hironobu Minami,Yuichiro Ohe,Kazuo Tamura,Nagahiro Saijo

PubMedno. 1 (2024): 45-52

引用0浏览0WOS引用

Clinical Significance of Inter-Assay Discrepancy in PD-L1 Evaluation for the Efficacy of Pembrolizumab in Advanced NSCLC with High PD-L1 Expression

Jun Miyakoshi,Jumpei Kashima,Masayuki Shirasawa,Masahiro Torasawa,Yuji Matsumoto,Ken Masuda,Yuki Shinno,Yusuke Okuma,Tatsuya Yoshida,Yasushi Goto,Hidehito Horinouchi,Kouya Shiraishi,Takashi Kohno,Noboru Yamamoto,Yasushi Yatabe,Yuichiro Ohe

Lung Cancer (2024): 107788-107788

引用0浏览0WOS引用

Protocol Summary of a Randomized Phase III Study: Comparing Systemic Therapy with and Without Debulking Surgery (primary Tumour Resection) for Clinical Stage IVA (Ct1-2Bn0-1m1a) Non-Small Cell Lung Cancer with Radiologically Undetermined Pleural Dissemination JCOG2103 (DEBULK-LUNG)

Yuta Sekino,Tomoyuki Hishida,Hiroshige Yoshioka,Masashi Wakabayashi,Noriko Mitome,Satoshi Shiono,Hirotsugu Kenmotsu,Kaname Nosaki,Keiju Aokage,Hidehito Horinouchi,Haruhiko Fukuda,Yuichiro Ohe,Shun-ichi Watanabe

JAPANESE JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0WOS引用

Efficacy and Safety of First-line Immunotherapy Plus Chemotherapy in Treating Elderly Patients with Extensive-stage Small Cell Lung Cancer

M. Sonoda,Y. Shinno, K. Tamura, Y. Yamaguchi, J. Miyakoshi, A. Tateishi, Y. Ikawa,M. Torasawa,M. Shirasawa,T. Yoshida,Y. Okuma,Y. Goto,H. Horinouchi,N. Yamamoto,Y. Ohe

B109 DIVING INTO DISCOVERY CURRENTS OF BASIC SCIENCE AND IMMUNOTHERAPIES IN LUNG CANCER (2024)

引用0浏览0引用

Abstract 5146: Clinical significance of inter-assay discrepancy in PD-L1 expression evaluation for the efficacy of pembrolizumab in advanced NSCLC patients with high PD-L1 expression

Cancer Researchno. 6_Supplement (2024): 5146-5146

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn